γ-aminobutyric acid transporter-1 is involved in anxiety-like behaviors and cognitive function in knockout mice

Gong,Xue; Shao,Yiye; Li,Bing; Chen,Long; Wang,Cuicui; Chen,Yinghui

doi:10.3892/etm.2015.2577

γ-aminobutyric acid transporter-1 is involved in anxiety-like behaviors and cognitive function in knockout mice

Authors:
- Xue Gong
- Yiye Shao
- Bing Li
- Long Chen
- Cuicui Wang
- Yinghui Chen
View Affiliations

Affiliations: Department of Neurology, Jinshan Hospital, Fudan University, Shanghai 201508, P.R. China, Center Laboratory, Jinshan Hospital, Fudan University, Shanghai 201508, P.R. China
Published online on: June 15, 2015 https://doi.org/10.3892/etm.2015.2577
Pages: 653-658

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect of γ-aminobutyric acid transporter-1 (GAT-1) on the anxiety‑like behaviors and cognitive function in knockout mice. In total, 20 adult male mice were divided into two groups, namely the GAT‑1 knockout (GAT‑1‑/‑) and wild‑type (WT) groups. The open field test, elevated 0‑maze (EZM) and Morris water maze were used to evaluate changes in anxiety‑like behaviors and cognitive function. Compared with the WT mice, GAT‑1‑/‑ mice made more entries and spent a longer time within the central area, traveling a greater distance, during the open field test (P<0.05). The EZM revealed that GAT‑1‑/‑ mice spent more time in the open sectors and made more total entries when compared with the WT mice (P<0.01). Observations from the two tests indicated reduced anxiety‑like behaviors in the GAT‑1‑/‑ mice. During the learning session using a Morris water maze, the latency to find the platform was significantly longer in the GAT‑1‑/‑ mice when compared with the WT mice (P<0.01). In addition, during the probe test, the GAT‑1‑/‑ mice spent less time in the target quadrant and more time in the opposite quadrant when compared with the WT mice (P<0.01); thus, the cognitive function in the GAT‑1‑/‑ mice was impaired. Therefore, the results demonstrated that the anxiety‑like behaviors were reduced and cognitive function was impaired in GAT‑1 knockout mice, indicating that GAT‑1 is involved in anxiety and cognitive functions.

View Figures

View References

1	Hu J and Quick MW: Substrate-mediated regulation of gamma-aminobutyric acid transporter 1 in rat brain. Neuropharmacology. 54:309–318. 2008. View Article : Google Scholar : PubMed/NCBI
2	Chiu CS, Brickley S, Jensen K, et al: GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum. J Neurosci. 25:3234–3245. 2005. View Article : Google Scholar : PubMed/NCBI
3	Kanner BI: Structure and function of sodium-coupled GABA and glutamate transporters. J Membr Biol. 213:89–100. 2006. View Article : Google Scholar : PubMed/NCBI
4	Liu QR, Lόpez-Corcuera B, Mandiyan S, Nelson H and Nelson N: Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain [corrected]. J Biol Chem. 268:2106–2112. 1993.PubMed/NCBI
5	Chiu CS, Jensen K, Sokolova I, et al: Number, density and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions. J Neurosci. 22:10251–10266. 2002.PubMed/NCBI
6	Ueda Y and Willmore LJ: Hippocampal γ-aminobutyric acid transporter alterations following focal epileptogenesis induced in rat amygdala. Brain Res Bull. 52:357–361. 2000. View Article : Google Scholar : PubMed/NCBI
7	Guastella J, Nelson N, Nelson H, et al: Cloning and expression of a rat brain GABA transporter. Science. 249:1303–1306. 1990. View Article : Google Scholar : PubMed/NCBI
8	Keros S and Hablitz JJ: Subtype-specific GABA transporter antagonists synergistically modulate phasic and tonic GABAA conductances in rat neocortex. J Neurophysiol. 94:2073–2085. 2005. View Article : Google Scholar : PubMed/NCBI
9	Lydiard RB: The role of GABA in anxiety disorders. J Clin Psychiatry. 64:(Suppl 3). 21–27. 2003.PubMed/NCBI
10	Rudolph U and Möhler H: GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol. 6:18–23. 2006. View Article : Google Scholar : PubMed/NCBI
11	Kalueff AV: Neurobiology of memory and anxiety: from genes to behavior. Neural Plast. 2007:781712007.PubMed/NCBI
12	Zarrindast MR, Bakhsha A, Rostami P and Shafaghi B: Effects of intrahippocampal injection of GABAergic drugs on memory retention of passive avoidance learning in rats. J Psychopharmacol. 16:313–319. 2002. View Article : Google Scholar : PubMed/NCBI
13	Zarrindast MR, Noorbakhshnia M, Motamedi F, Haeri-Rohani A and Rezayof A: Effect of the GABAergic system on memory formation and state-dependent learning induced by morphine in rats. Pharmacology. 76:93–100. 2006. View Article : Google Scholar : PubMed/NCBI
14	Prut L and Belzung C: The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 463:3–33. 2003. View Article : Google Scholar : PubMed/NCBI
15	Gong N, Li Y, Cai GQ, et al: GABA transporter-1 activity modulates hippocampal theta oscillation and theta burst stimulation-induced long-term potentiation. J Neurosci. 29:15836–15845. 2009. View Article : Google Scholar : PubMed/NCBI
16	Huang Y, Hu Z, Liu G, Zhou W and Zhang Y: Cytokines induced by long-term potentiation (LTP) recording: a potential explanation for the lack of correspondence between learning/memory performance and LTP. Neuroscience. 231:432–443. 2013. View Article : Google Scholar : PubMed/NCBI
17	Treit D and Fundytus M: Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav. 31:959–962. 1988. View Article : Google Scholar : PubMed/NCBI
18	Shin J, Gireesh G, et al: Phospholipase C beta 4 in the medial septum controls cholinergic theta oscillations and anxiety behaviors. J Neurosci. 29:15375–15385. 2009. View Article : Google Scholar : PubMed/NCBI
19	Coutellier L, Friedrich AC, Failing K, Marashi V and Würbel H: Effects of foraging demand on maternal behaviour and adult offspring anxiety and stress response in C57BL/6 mice. Behav Brain Res. 196:192–199. 2009. View Article : Google Scholar : PubMed/NCBI
20	Coutellier L, Friedrich AC, Failing K, Marashi V and Würbel H: Effects of foraging demand on maternal behaviour and adult offspring anxiety and stress response in C57BL/6mice. Behav Brain Res. 196:192–199. 2009. View Article : Google Scholar : PubMed/NCBI
21	Morris RG, Garrud P, Rawlins JN and O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature. 297:681–683. 1982. View Article : Google Scholar : PubMed/NCBI
22	Argyropoulos SV, Sandford JJ and Nutt DJ: The psychobiology of anxiolytic drugs: Part 2: pharmacological treatments of anxiety. Pharmacol Ther. 88:213–227. 2000. View Article : Google Scholar : PubMed/NCBI
23	Beleboni RO, Carolino ROG, Pizzo AB, et al: Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships. Cell Mol Neurobiol. 24:707–728. 2004. View Article : Google Scholar : PubMed/NCBI
24	Stahl SM: Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA. J Clin Psychiatry. 65:291–292. 2004. View Article : Google Scholar : PubMed/NCBI
25	Liu GX, Cai GQ, Cai YQ, et al: Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacol. 32:1531–1539. 2007. View Article : Google Scholar
26	Thoeringer CK, Ripke S, Unschuld PG, et al: The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. J Neural Transm. 116:649–657. 2009. View Article : Google Scholar : PubMed/NCBI
27	Kälviäinen R: Cognitive effects of GABAergic antiepileptic drugs. Electroencephalogr Clin Neurophysiol Suppl. 50:458–464. 1999.PubMed/NCBI
28	O'Connell AW, Fox GB, Kjøller C, et al: Anti-ischemic and cognition-enhancing properties of NNC-711, a γ-aminobutyric acid reuptake inhibitor. Eur J Pharmacol. 424:37–44. 2001. View Article : Google Scholar : PubMed/NCBI
29	Schmitt U and Hiemke C: Tiagabine, a γ-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze. Behav Brain Res. 133:391–394. 2002. View Article : Google Scholar : PubMed/NCBI
30	Hu JH, Ma YH, Jiang J, et al: Cognitive impairment in mice over-expressing [gamma]-aminobutyric acid transporter I (GAT1). Neuroreport. 15:9–12. 2004. View Article : Google Scholar : PubMed/NCBI
31	Richerson GB and Wu Y: Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore. J Neurophysiol. 90:1363–1374. 2003. View Article : Google Scholar : PubMed/NCBI
32	Richerson GB and Wu Y: Role of the GABA transporter in epilepsy. Recent Advances in Epilepsy Research. Binder DK and Scharfman HE: Springer; New York, NY: pp. 76–91. 2004, View Article : Google Scholar
33	Whitlock JR, Heynen AJ, Shuler MG and Bear MF: Learning induces long-term potentiation in the hippocampus. Science. 313:1093–1097. 2006. View Article : Google Scholar : PubMed/NCBI
34	Shi J, Cai Y, Liu G, et al: Enhanced learning and memory in GAT1 heterozygous mice. Acta Biochim Biophys Sin (Shanghai). 44:359–366. 2012. View Article : Google Scholar : PubMed/NCBI